Rocuronium-spl-carton-100-mg (Rocuronium Spl Carton 100 mg)
Rocuronium Bromide Injection, Solution
Product Images NDC 0409-5160
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 0409-5160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Rocuronium-spl-carton-50-mg (Rocuronium Spl Carton 50 mg)
Not available.*
Rocuronium-spl-fig-1 (Rocuronium Spl Fig 1)
Rocuronium-spl-fig-2 (Rocuronium Spl Fig 2)
Rocuronium-spl-fig-3 (Rocuronium Spl Fig 3)
Rocuronium-spl-fig-4 (Rocuronium Spl Fig 4)
Rocuronium-spl-structure (Rocuronium Spl Structure)
Rocuronium-spl-vial-100-mg (Rocuronium Spl Vial 100 mg)
Rocuronium-spl-vial-50-mg (Rocuronium Spl Vial 50 mg)
NDC 0409-1403-05 is a multiple dose vial of Rocuronium Bromide Injection. Each vial contains 50 mg of Rocuronium in a 5 mL solution. This medication is a paralyzing agent to be used only for intravenous use. It is important to note that it can cause respiratory arrest, so facilities with immediate access to artificial respiration must be available. The medication should be stored in a refrigerator between 2 to 8 degrees Celsius and should not be frozen. Once removed from refrigeration, it should be used within 60 days if stored at room temperature, and opened vials should be used within 30 days. This product is distributed by Hospira, Inc. and the packaging is latex-free.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
